Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor

Details for Australian Patent Application No. 2002255961 (hide)

Owner Cytokine PharmaSciences, Inc

Inventors Bucala, Richard J.; Leng, Lin; Metz, Christine N.

Agent Spruson & Ferguson

Pub. Number AU-B-2002255961

PCT Pub. Number WO2002/079517

Priority 60/279,435 29.03.01 US

Filing date 29 March 2002

Wipo publication date 15 October 2002

Acceptance publication date 23 August 2007

International Classifications

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

A61K 31/7084 (2006.01) - Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/10 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 33/00 (2006.01) Antiparasitic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

3 April 2003 Application Open to Public Inspection

  Published as AU-B-2002255961

8 June 2006 Assignment before Grant

  The Picower Institute for Medical Research The application has been assigned to Cytokine PharmaSciences, Inc

26 July 2007 Amendment Made

  The nature of the amendment is: Delete co-inventors Donnelly, Seamas and Mitchell, Robert.

23 August 2007 Application Accepted

  Published as AU-B-2002255961

20 December 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002255962-METHOD AND APPARATUS FOR DELIVERING MESSAGES TO WIRELESS DEVICES

2002255960-Hand-held surgical instruments with omni-circumferential actuation capabilities